Also, the pancreatic beta-cell mass has been addressed as well as insulin levels to confirm early-stage T1D, with reduction of beta-cell mass and insulin levels in STZ-treated mice (Supplementary Figures 6, 7). This evidence concerns the gene INS and type 1 diabetes mellitus.